Gracell Biotechnologies

-$0.09 (-2.91%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GRCL and other ETFs, options, and stocks.

About GRCL

Gracell Biotechnologies, Inc. engages in the research and development activities of biotechnological and pharmaceutical industries. The firm through its FasTCAR and TruUCAR platforms, it is developing a pipeline of autologous and allogeneic cell therapy candidates with the potential to treat both hematologic malignancies and solid tumors.

CEO
Wei Cao
Employees
348
Headquarters
Suzhou, Shanghai
Founded
2017

GRCL Key Statistics

Market cap
207.77M
Price-Earnings ratio
—
Dividend yield
—
Average volume
137.29K
High today
$3.31
Low today
$2.97
Open price
$3.06
Volume
63.09K
52 Week high
$16.98
52 Week low
$1.68

GRCL Earnings

-$0.75
-$0.50
-$0.25
$0.00
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Estimated
-$0.21 per share
Actual
-$0.35 per share
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure